Symptomatic hypercalcemia in a patient with chronic tophaceous gout: a case report.
MetadataShow full item record
AbstractABSTRACT: Hypercalcemia has been widely associated with granulomatous processes. This is due to enhanced extra-renal conversion of calcidiol to calcitriol by activated macrophages within the granuloma. Symptomatic hypercalcemia due to granulomatous disorders is not common, with the incidence in sarcoidosis ranging from 10-20%. Large aggregates of monosodium urate crystals in patients with longstanding chronic tophaceous gout can serve as the inciting antigen for the development of granuloma, but hypercalcemia has not been described in this context. We report a case of symptomatic hypercalcemia due to gouty tophi induced granulomatous inflammation. Long term treatment with immunosuppressants, in addition to bisphosphonates and uric acid lowering therapy, has led to stabilization of serum calcium levels and other lab parameters indicative of granulomatous burden.
CitationCases J. 2008 Aug 7; 1:72
- Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
- Authors: Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A
- Issue date: 2002 Aug
- Immobilization hypercalcemia-associated acute renal failure in a patient with chronic tophaceous gout.
- Authors: Lee KA, Yoo WH
- Issue date: 2009
- Severe Hypercalcaemia - Chronic Tophaceous Gout as the Responsible Cause?
- Authors: Rodríguez-Gutiérrez R, Zapata-Rivera MA, Rodriguez-Velver KV, Lavalle-Gonzalez FJ, Gonzalez-Gonzalez JG, Villarreal-Perez JZ
- Issue date: 2015 Aug
- Intradermal urate tophi.
- Authors: Fam AG, Assaad D
- Issue date: 1997 Jun
- Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
- Authors: Perez-Ruiz F, Atxotegi J, Hernando I, Calabozo M, Nolla JM
- Issue date: 2006 Oct 15